Investors Are Selling a Record Share of Homes To Cut Their Losses—Especially in These 5 States
Individual homeowners hesitated to list their homes last year due to surging mortgage interest rates—but real estate investors plowed right ahead, pushing the share of homes they sold to an all-time high.
In 2024, just under 11% of all homes sold in the U.S. came from real estate investors, the highest share in the data's history going back to 2001, according to the latest Realtor.com® Investor Report released on Tuesday. The median sale amount for investor properties was about $330,000.
Investor home sales ticked up by 5.2% year over year in 2024, outpacing the increase in investor buyer activity.
Looking at the raw sales numbers, investors offloaded about 509,000 properties last year, which was fewer than in 2021 and 2022, but significantly higher than pre-pandemic levels.
'The reason behind investor sales has shifted since the [COVID-19] pandemic heyday,' says Realtor.com senior economic research analyst Hannah Jones. 'Investors may no longer be selling to cash in on soaring home values, but rather due to market softening and easing rents.'
Simply put, investors who own rental properties saw rent prices begin to slip, and they sprang into action to cut their losses.
Of all 50 states, Missouri and Oklahoma saw the highest share of investor sellers in 2024, at 16.7% each, up 0.5% and 1.7% from 2023, respectively.
Georgia came a close second, with investors making up 15.9% of all home sellers last year, followed by Kansas with 14.3%.
Utah rounded out the top five, with investors accounting for 14.3% of all sellers in the state in 2024.
What's more, the list of top states for investor sellers looks similar to the top regions for investor buyers, suggesting that certain markets attract heightened investor activity across the board.
Overall, 13% of homes purchased in 2024 were snapped up by investor buyers, up only slightly from 12.7% the year before, according to the new report.
'Though modest, this increase in investor home purchases came at a time when overall home purchasing slumped, resulting in an uptick in investor buyer share,' explains Jones.
Missouri saw the highest share of investors buying homes, at 21.2%, followed by Oklahoma, at 18.7%, and Kansas, at 18.4%. Utah and Georgia notched the two final spots in the top five, at 18% and 17.3%, respectively.
The common denominator among these five states, according to economists, is that they are generally affordable but have higher rental prices than the national median, making those areas especially attractive to investors.
'Buying a home is still relatively affordable in these states, making them more hospitable for investors,' adds Jones. 'Overall buyer activity has pulled back significantly as housing costs have climbed over the last few years. Investor activity has mirrored this pullback to some degree, but investors continue to find opportunities in low-priced markets with strong demand.'
A closer look at investor hot spots shows that out of the 50 largest metro markets, Memphis, TN, Oklahoma City, St. Louis, Kansas City, MO, and Birmingham, AL, saw the highest investor buyer shares.
Jones points out that the top 10 markets for investor buyers were all clustered in the South and Midwest—the two most budget-friendly U.S. regions.
Mirroring state-level trends, the cities with the highest percentages of investor buyers also tended to have a higher share of investor sellers—with Memphis, Oklahoma City, and Kansas City topping the list.
Looking at this data analysis, a key question arises: Do investor buyers help or hurt the housing market? Perhaps unsurprisingly, the answer is not straightforward.
The U.S. as a whole continues to suffer from a severe housing supply shortage, now estimated at roughly 4 million homes. While investor buyers help make more rental units available, their purchasing sprees tend to make for-sale inventory ever more scarce, because they compete directly with individual homebuyers.
Last year, the typical investor bought a home for $282,000, more than $70,000 below the national median sale price. These figures indicate that investors gravitate toward the most affordable markets and are drawn to cheaper properties, which they can then rent out to turn a profit.
'As a result, budget-conscious buyers often find themselves in direct competition with investors for the most affordable properties, a contest many are unable to win,' says Jones.
Notably, the push to sell affected all investor groups across the board, from mom-and-pop outfits to big-time players in the industry.
Realtor.com economists define small investors as those who have bought fewer than 10 homes under their entity, medium investors as 10-50 purchases, and large investors as more than 50 purchases.
Jones stresses that all three types of investors sold more homes last year compared with 2023, signaling a shift in the market.
Small-time investors offloaded a total of 270,000 homes in 2024, the third-highest number in the data's history, behind 2021 and 2022.
On the other hand, major investment firms sold 123,800 homes, higher than the previous year, but lower than in 2021 and 2022.
Meanwhile, while all investor sizes bought more homes than they sold in 2024, the gap was the smallest in the data's 24-year history for large and medium investors.
Big-time players purchased only 8,700 more homes than they sold in 2024, down from 134,000 more homes bought than sold by this group at the peak in 2021.
Medium investors bought fewer than 250 more homes than they sold in 2024. That's down from 25,000 more homes they bought than sold in 2022.
In this analysis, Realtor.com economists examined deed records for single-family homes, condos, townhomes, and row houses dating from January 2000 to February 2025 nationally, on the state level and in the 50 largest metros.
Economists looked only at absentee owners with a name that includes 'LLP,' 'LP,' 'LLC,' 'GP,' or 'TRUST,' and excluded keywords and sales that were likely related to homebuilders, relocation companies, government bodies, and financial institutions.
The Next Great Quake Could Triple Flood Risk in the Pacific Northwest
'I Turned My Rent-Stabilized Childhood Home Into a Stunning New York City Palace'
'Let It Bloom' June Is One Landscaping Trend Homeowners Really Should Ignore This Summer

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


USA Today
an hour ago
- USA Today
Who's listening to Negative Nelly? Not these investors. Survey shows they're optimistic.
Who's listening to Negative Nelly? Not these investors. Survey shows they're optimistic. Show Caption Hide Caption The trade war hits stock markets — how can you protect your finances? The global trade war has hit the stock markets — this is how you can protect your finances. Americans may have gotten pretty good at tuning out negative news and predictions, at least when it comes to investing, a Wealthfront survey suggests. Individuals surveyed by investment platform Wealthfront continued investing through the April U.S. stock market volatility stemming from President Donald Trump's tariff back-and-forth, and nearly 30% say they plan to invest more in U.S. stocks in the future. That may seem counterintuitive considering the many dire forecasts for the economy and the stock market from tariff wars, but 'it's also possible that investors are getting better at handling the constant flow of headlines and uncertainties that have shaped the market lately,' said Alex Michalka, head of investment strategy at Wealthfront. Optimism rises In May, 55% of respondents said they were somewhat or very optimistic about the U.S. stock market over the next six months. That's significantly higher than the 42% in April who felt upbeat. The improved vibes are 'likely fueled by the postponement of tariffs and the growing perception that future trade policies could be more moderate than initially anticipated,' Michalka said. Since Trump first announced his aggressive tariff plan on April 2, some of the highest tariffs have been iced as the administration tries to strike trade deals. The latest, and arguably the most significant, talks are occurring this week in London with Chinese officials. Is the worst over? Market volatility isn't necessarily over, and it can be uncomfortable for investors, but it's a fact of life, Michalka said. Once people understand and accept that, it's easier to stay the course and remain optimistic. 'During Covid, stocks went down really fast, but they also came back really fast,' said Nick Bour, founder and chief executive of Inspire Wealth in Brighton, Michigan. 'If you get out, you could miss the big bounce back.' Stocks ended May up 6% and are up again on the year. Additionally, if you took advantage of tax-loss harvesting and dollar-cost averaging during the volatility earlier this year, you may have even done better. Tax-loss harvesting means selling stocks that are losing money, recognizing the loss, and using it to offset capital gains, or profits made from other holdings, even if they are different types of investments or are being held in different accounts. Dollar-cost averaging is buying stock at regular intervals, regardless of whether prices are falling or rising. 'Not only did you buy investments 'at a discount,' you should have potentially valuable losses to use to lower your tax bill come tax time next year,' Michalka said. Medora Lee is a money, markets, and personal finance reporter at USA TODAY. You can reach her at mjlee@ and subscribe to our free Daily Money newsletter for personal finance tips and business news every Monday through Friday morning.
Yahoo
an hour ago
- Yahoo
Biovica Signs Agreement with Fifth Tier-1 US Biopharma Company
UPPSALA, SE / / June 11, 2025 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) - Biovica, active in blood-based cancer monitoring, has signed a new Master Service Agreement (MSA) - along with an initial Work Order of ~800 kSEK - with a Tier-1 US-based biopharmaceutical company. The new customer, a global leader in oncology drug development, becomes the fifth Tier-1 US biopharma company to join Biovica's Pharma Services customer base. The agreement covers testing of Phase 1 clinical trial samples in support of the development of next-generation CDK4/6 inhibitors and is a pilot study with DiviTum® TKa. " This marks a milestone in our growing customer base, highlighting the increasing relevance of Biovica's TKa biomarker assay in advanced cancer therapy development. It demonstrates the strong and growing recognition of the value our assay brings to the development of next-generation oncology treatments that ultimately benefit cancer patients. ," said Anders Rylander, CEO of Biovica. Contact Anders Rylander, CEOPhone: +46 76 666 16 47E-mail: Anders Morén, CFOPhone: +46 73 125 92 46E-mail: Biovica - Treatment decisions with greater confidence Biovica develops and commercializes blood-based biomarker assays that help oncologists monitor cancer progression. Biovica's assay, DiviTum® TKa, measures cell proliferation by detecting the TKa biomarker in the bloodstream. The assay has demonstrated its ability to provide insight to therapy effectiveness in several clinical trials. The first application for the DiviTum® TKa test is treatment monitoring of patients with metastatic breast cancer. Biovica's vision is: "Improved care for cancer patients." Biovica collaborates with world-leading cancer institutes and pharmaceutical companies. DiviTum® TKa has received FDA 510(k) clearance in the US and is CE-marked in the EU. Biovica's shares are traded on the Nasdaq First North Premier Growth Market (BIOVIC B). FNCA Sweden AB is the company's Certified Adviser. For more information, please visit: Attachments Biovica signs agreement with fifth Tier-1 US biopharma company SOURCE: Biovica International View the original press release on ACCESS Newswire Sign in to access your portfolio


Hamilton Spectator
3 hours ago
- Hamilton Spectator
Milton downtown small businesses seek financial support
Milton's downtown core is home to a vibrant business community, with more than 185 businesses operating in the area — approximately 82 per cent of them classified as small businesses, according to the Town of Milton. The Downtown Milton Business Improvement Area (DMBIA) represents more than 220 business operators and property owners, reflecting the area's dynamic and evolving commercial landscape. However, since the COVID-19 pandemic, many local shops have struggled to recover financially. While public spending habits have shifted back to in-person shopping, many residents continue to favour national chains over local downtown businesses — limiting economic recovery for the small business community. Avery Teal, social media co-ordinator at the Milton Chamber of Commerce, said the Chamber has been working to promote local businesses through various media platforms. 'We've been helping small businesses increase their visibility through platforms like Instagram, TikTok and LinkedIn,' Teal said. 'The goal is to bring more attention to the businesses that make Milton unique.' As part of the Chamber's outreach, Dan Rogers, owner of RX Recourse — a corporate fitness and wellness service based downtown — partnered with the Chamber to produce a promotional video. The video, posted to LinkedIn, featured Rogers explaining his services, including 'Team Building 101.' 'The Milton Chamber of Commerce was kind enough to help me build a commercial to briefly explain what I do,' Rogers said in a post. The video served as a tool to boost visibility for RX Recourse within the local community. In addition to the Chamber's efforts, the Milton BIA partnered with Digital Main Street Ontario to launch a Digital Service Squad (DSS). The initiative offered one-on-one support for small businesses looking to improve their digital presence, including website creation and marketing strategy development. Mira Nasser, events manager at the BIA, said the program offered grants of up to $2,500 for digital upgrades. In total, $80,000 in funding was distributed to support 32 businesses in Milton. Error! Sorry, there was an error processing your request. There was a problem with the recaptcha. Please try again. You may unsubscribe at any time. By signing up, you agree to our terms of use and privacy policy . This site is protected by reCAPTCHA and the Google privacy policy and terms of service apply. Want more of the latest from us? Sign up for more at our newsletter page .